RYTM Current Ratio

The Current Ratio of Rhythm Pharmaceuticals, Inc. (RYTM) is 4.41.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

RYTM Current Ratio - Historical Value

Date	Value
2025-12-31	4.41
2024-12-31	3.24
2023-12-31	5.58
2022-12-31	8.90
2021-12-31	7.11
2020-12-31	10.09
2019-12-31	12.39
2018-12-31	19.02
2017-12-31	22.49
2016-12-31	2.38

RYTM Current Ratio - Peers Comparison

Ticker	Name	Value
AKRO	Akero Therapeutics Inc	19.25
TSHA	Taysha Gene Therapies, Inc.	12.23
ABBV	AbbVie Inc.	0.67
AVXL	Anavex Life Sciences Corp	11.60
CMPS	Compass Pathways PLC	0.77
GILD	Gilead Sciences, Inc.	1.55
MRSN	Mersana Therapeutics Inc	2.19
NWBO	Northwest Biotherapeutics Inc	0.06
PASG	Passage Bio Inc	2.07
DVAX	Dynavax Technologies Corp	10.80
VRTX	Vertex Pharmaceuticals Incorporated	2.90
950200.KQ	Psomagen Inc	1.67
REGN	Regeneron Pharmaceuticals, Inc.	4.13
TRIL.TO	Trillium Therapeutics Inc	13.95
YMAB	Y-mAbs Therapeutics Inc	4.16
PCVX	Vaxcyte, Inc.	7.91
950220.KQ	Neoimmunetech Inc	3.08
ARCT	Arcturus Therapeutics Holdings Inc	6.64
BTAI	BioXcel Therapeutics Inc	0.83
CRTX	Cortexyme Inc	7.85
EPIX	ESSA Pharma Inc	38.79
FDMT	4D Molecular Therapeutics Inc	9.39
ITOS	iTeos Therapeutics Inc	12.75
ANNX	Annexon, Inc.	5.68
ATRA	Atara Biotherapeutics, Inc.	0.82
PRTA	Prothena Corporation PLC	7.72
950160.KQ	Kolon TissueGene Inc	0.24
AFMD	Affimed NV	3.25
CYDY	Cytodyn Inc	0.26
KNSA	Kiniksa Pharmaceuticals International, PLC	3.79
KROS	Keros Therapeutics, Inc.	15.45
ORIC	ORIC Pharmaceuticals, Inc.	14.13
STOK	Stoke Therapeutics, Inc.	5.28
AMGN	Amgen Inc	1.14
MRNA	Moderna, Inc.	3.29
PRAX	Praxis Precision Medicines, Inc.	10.22
SNDX	Syndax Pharmaceuticals, Inc.	4.40